BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 24389226)

  • 21. The PGI-KLF4 pathway regulates self-renewal of glioma stem cells residing in the mesenchymal niches in human gliomas.
    Zhu XY; Wang L; Luan SH; Zhang HS; Huang WT; Wang NH
    Neoplasma; 2014; 61(4):401-10. PubMed ID: 24645841
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Repurposing FDA approved drugs inhibiting mitochondrial function for targeting glioma-stem like cells.
    Datta S; Sears T; Cortopassi G; Woolard K; Angelastro JM
    Biomed Pharmacother; 2021 Jan; 133():111058. PubMed ID: 33378970
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fatty acid binding protein 7 as a marker of glioma stem cells.
    Morihiro Y; Yasumoto Y; Vaidyan LK; Sadahiro H; Uchida T; Inamura A; Sharifi K; Ideguchi M; Nomura S; Tokuda N; Kashiwabara S; Ishii A; Ikeda E; Owada Y; Suzuki M
    Pathol Int; 2013 Nov; 63(11):546-53. PubMed ID: 24274717
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular markers in glioma.
    Ludwig K; Kornblum HI
    J Neurooncol; 2017 Sep; 134(3):505-512. PubMed ID: 28233083
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The U2AF2 /circRNA ARF1/miR-342-3p/ISL2 feedback loop regulates angiogenesis in glioma stem cells.
    Jiang Y; Zhou J; Zhao J; Zhang H; Li L; Li H; Chen L; Hu J; Zheng W; Jing Z
    J Exp Clin Cancer Res; 2020 Sep; 39(1):182. PubMed ID: 32894165
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glioma Stem Cells but Not Bulk Glioma Cells Upregulate IL-6 Secretion in Microglia/Brain Macrophages via Toll-like Receptor 4 Signaling.
    Dzaye O; Hu F; Derkow K; Haage V; Euskirchen P; Harms C; Lehnardt S; Synowitz M; Wolf SA; Kettenmann H
    J Neuropathol Exp Neurol; 2016 May; 75(5):429-40. PubMed ID: 27030742
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Down-modulation of SEL1L, an unfolded protein response and endoplasmic reticulum-associated degradation protein, sensitizes glioma stem cells to the cytotoxic effect of valproic acid.
    Cattaneo M; Baronchelli S; Schiffer D; Mellai M; Caldera V; Saccani GJ; Dalpra L; Daga A; Orlandi R; DeBlasio P; Biunno I
    J Biol Chem; 2014 Jan; 289(5):2826-38. PubMed ID: 24311781
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oncogenic and Tumor-Suppressive Functions of NOTCH Signaling in Glioma.
    Parmigiani E; Taylor V; Giachino C
    Cells; 2020 Oct; 9(10):. PubMed ID: 33076453
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Brain tumor stem cells as therapeutic targets in models of glioma.
    Laks DR; Visnyei K; Kornblum HI
    Yonsei Med J; 2010 Sep; 51(5):633-40. PubMed ID: 20635435
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting glioma stem cells: enough to terminate gliomagenesis?
    Dong J; Huang Q
    Chin Med J (Engl); 2011 Sep; 124(17):2756-63. PubMed ID: 22040437
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autophagy-induced KDR/VEGFR-2 activation promotes the formation of vasculogenic mimicry by glioma stem cells.
    Wu HB; Yang S; Weng HY; Chen Q; Zhao XL; Fu WJ; Niu Q; Ping YF; Wang JM; Zhang X; Yao XH; Bian XW
    Autophagy; 2017 Sep; 13(9):1528-1542. PubMed ID: 28812437
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glioma stem cell-derived exosomal miR-944 reduces glioma growth and angiogenesis by inhibiting AKT/ERK signaling.
    Jiang J; Lu J; Wang X; Sun B; Liu X; Ding Y; Gao G
    Aging (Albany NY); 2021 Jul; 13(15):19243-19259. PubMed ID: 34233294
    [TBL] [Abstract][Full Text] [Related]  

  • 33. QKI deficiency maintains glioma stem cell stemness by activating the SHH/GLI1 signaling pathway.
    Han B; Wang R; Chen Y; Meng X; Wu P; Li Z; Duan C; Li Q; Li Y; Zhao S; Jiang C; Cai J
    Cell Oncol (Dordr); 2019 Dec; 42(6):801-813. PubMed ID: 31292920
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extracellular Vesicles from High-Grade Glioma Exchange Diverse Pro-oncogenic Signals That Maintain Intratumoral Heterogeneity.
    Ricklefs F; Mineo M; Rooj AK; Nakano I; Charest A; Weissleder R; Breakefield XO; Chiocca EA; Godlewski J; Bronisz A
    Cancer Res; 2016 May; 76(10):2876-81. PubMed ID: 27013191
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Imaging glioma initiation in vivo through a polished and reinforced thin-skull cranial window.
    Zhang L; Lapierre A; Roy B; Lim M; Zhu J; Wang W; Sampson SB; Yun K; Lyons B; Li Y; Lin DT
    J Vis Exp; 2012 Nov; (69):. PubMed ID: 23207870
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Indoleamine 2,3-dioxygenase 1 is highly expressed in glioma stem cells.
    Ozawa Y; Yamamuro S; Sano E; Tatsuoka J; Hanashima Y; Yoshimura S; Sumi K; Hara H; Nakayama T; Suzuki Y; Yoshino A
    Biochem Biophys Res Commun; 2020 Apr; 524(3):723-729. PubMed ID: 32035622
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interaction of tumor-associated microglia/macrophages and cancer stem cells in glioma.
    Zhu X; Fang Y; Chen Y; Chen Y; Hong W; Wei W; Tu J
    Life Sci; 2023 May; 320():121558. PubMed ID: 36889666
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autofluorescence of NADH is a new biomarker for sorting and characterizing cancer stem cells in human glioma.
    Yuan Y; Yan Z; Miao J; Cai R; Zhang M; Wang Y; Wang L; Dang W; Wang D; Xiang D; Wang Y; Zhang P; Cui Y; Bian X; Ma Q
    Stem Cell Res Ther; 2019 Nov; 10(1):330. PubMed ID: 31747975
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IDH1 mutation diminishes aggressive phenotype in glioma stem cells.
    Yao Q; Cai G; Yu Q; Shen J; Gu Z; Chen J; Shi W; Shi J
    Int J Oncol; 2018 Jan; 52(1):270-278. PubMed ID: 29115585
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Malignant glioma: lessons from genomics, mouse models, and stem cells.
    Chen J; McKay RM; Parada LF
    Cell; 2012 Mar; 149(1):36-47. PubMed ID: 22464322
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.